| # | Drug | Count |
|---|---|---|
| 0 | RISANKIZUMAB-RZAA | 3 |
| 1 | ACETAMINOPHEN | 1 |
| 2 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 |
| 3 | ATOGEPANT | 1 |
| 4 | BEXAGLIFLOZIN | 1 |
| 5 | DEFERASIROX | 1 |
| 6 | INFLIXIMAB | 1 |
| 7 | INFLIXIMAB-DYYB | 1 |
| 8 | INTERFERON BETA-1A | 1 |
| 9 | LEUPROLIDE ACETATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEXAGLIFLOZIN | 1 | 0.0323 |
| 1 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 2 | ATOGEPANT | 1 | 0.0001 |
| 3 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0000 |
| 4 | DEFERASIROX | 1 | 0.0000 |
| 5 | PIOGLITAZONE | 1 | 0.0000 |
| 6 | ORAL SEMAGLUTIDE | 1 | 0.0000 |
| 7 | LEUPROLIDE ACETATE | 1 | 0.0000 |
| 8 | UPADACITINIB | 1 | 0.0000 |
| 9 | PEMBROLIZUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 1 | Iron Chelator [EPC] | 1 | 0.0000 |
| 2 | Interleukin-23 Antagonist [EPC] | 3 | 0.0000 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 4 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Interferon beta [EPC] | 1 | 0.0000 |
| 7 | Expectorant [EPC] | 1 | 0.0000 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 9 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |